Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1805.60x is 97% below its 5-year average of -917.77x, near the low end of its 5-year range (-4990.50x–10748.00x).
726.25% below its 12-month average of 288.32x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2026 (2026-03-31): 10748.00x.
INTEREST COVERAGE RATIO
-1805.60x
INTEREST COVERAGE RATIO AVG TTM
288.32x
INTEREST COVERAGE RATIO AVG 3Y
-1428.43x
INTEREST COVERAGE RATIO AVG 5Y
-917.77x
INTEREST COVERAGE RATIO AVG 10Y
-781.52x
INTEREST COVERAGE RATIO AVG 15Y
-730.49x
INTEREST COVERAGE RATIO AVG 20Y
-1196.00x
CURRENT VS TTM AVG
-726.25%
CURRENT VS 3Y AVG
-26.40%
CURRENT VS 5Y AVG
-96.74%
CURRENT VS 10Y AVG
-131.04%
CURRENT VS 15Y AVG
-147.18%
CURRENT VS 20Y AVG
-50.97%
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 488 covered companies
CURRENT VS SECTOR MEDIAN
-31084.80%
vs the sector median at left
Palisade Bio, Inc.
Market Cap
$261.24M
Interest Coverage Ratio
-1805.60x
TTM Avg
288.32x
3Y Avg
-1428.43x
5Y Avg
-917.77x
Market Cap
$260.96M
Interest Coverage Ratio
-360.54x
TTM Avg
23.12x
3Y Avg
23.12x
5Y Avg
1139.56x
Market Cap
$259.85M
Interest Coverage Ratio
-9.79x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$262.45M
Interest Coverage Ratio
-530.37x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$265.39M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$258.09M
Interest Coverage Ratio
N/A
TTM Avg
130.06x
3Y Avg
93.86x
5Y Avg
75.34x
Market Cap
$264.83M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$265.41M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$267.03M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Palisade Bio, Inc. (PALI) | $261.24M | -1805.60x | 288.32x | -1428.43x | -917.77x |
| AC Immune S.A. (ACIU)vs › | $260.96M | -360.54x | 23.12x | 23.12x | 1139.56x |
| X4 Pharmaceuticals, Inc. (XFOR)vs › | $259.85M | -9.79x | N/A | N/A | N/A |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $262.45M | -530.37x | N/A | N/A | N/A |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $265.39M | N/A | N/A | N/A | N/A |
| Anika Therapeutics, Inc. (ANIK)vs › | $258.09M | N/A | 130.06x | 93.86x | 75.34x |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $264.83M | N/A | N/A | N/A | N/A |
| OraSure Technologies, Inc. (OSUR)vs › | $265.41M | N/A | N/A | N/A | N/A |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $267.03M | N/A | N/A | N/A | N/A |
| Scribe Therapeutics Inc. (SCTX)vs › | $270.73M | N/A | N/A | N/A | N/A |
Interest Coverage
-1805.6x
Debt/Equity
0.00
Current Ratio
24.26
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | 10748.00x |
| 2025-12-31 | -4990.50x |
| 2025-09-30 | -584.40x |
| 2025-06-30 | -1421.50x |
| 2025-03-31 | -2310.00x |
| 2024-12-31 | -1127.33x |
| 2024-09-30 | -598.83x |
| 2024-06-30 | -2105.50x |
| 2024-03-31 | -3673.00x |
| 2023-12-31 | -788.50x |
| 2023-09-30 | -472.25x |
| 2023-06-30 | -1203.00x |
| 2022-12-31 | -1282.67x |
| 2022-09-30 | -1103.25x |
| 2022-06-30 | -714.40x |
| 2022-03-31 | -3888.00x |
| 2021-12-31 | -805.40x |
| 2021-09-30 | -116.00x |
| 2021-06-30 | -50.16x |
| 2021-03-31 | -1.14x |
| 2020-12-31 | -3.13x |
| 2020-09-30 | -64.86x |
| 2020-06-30 | -167.36x |
| 2020-03-31 | -928.27x |
| 2019-12-31 | -475.80x |
| 2019-09-30 | -1110.30x |
| 2019-06-30 | -3783.04x |
| 2019-03-31 | -1218.15x |
| 2018-12-31 | -514.54x |
| 2018-09-30 | -1390.52x |
| 2018-06-30 | -2620.47x |
| 2018-03-31 | -1223.44x |
| 2017-12-31 | -704.00x |
| 2017-09-30 | -1871.29x |
| 2017-06-30 | -268.18x |
| 2017-03-31 | -30.50x |
| 2016-12-31 | -29.45x |
| 2016-09-30 | -20.45x |
| 2016-06-30 | -11.89x |
| 2016-03-31 | -16.13x |
| 2015-12-31 | -9.91x |
| 2015-09-30 | -11.20x |
| 2015-06-30 | -10.88x |
| 2015-03-31 | -10.17x |
| 2014-12-31 | -10.82x |
| 2014-09-30 | -11.36x |
| 2014-06-30 | -8.83x |
| 2014-03-31 | -11.96x |
| 2013-12-31 | -6.04x |
| 2013-09-30 | -8.09x |
| 2013-06-30 | -7.37x |
| 2013-03-31 | -59.93x |
| 2012-12-31 | -2996.51x |
| 2012-09-30 | -7710.92x |
| 2012-06-30 | -3965.48x |
| 2012-03-31 | -2887.71x |
| 2011-12-31 | -3120.58x |
| 2010-12-31 | -44792.21x |
| 2010-09-30 | -8437.95x |
| 2010-06-30 | -2869.42x |
| 2010-03-31 | -5488.41x |
| 2009-12-31 | -3965.64x |
| 2009-09-30 | -13003.00x |
| 2007-12-31 | -13331.27x |
| 2007-06-30 | -5748.13x |
| 2007-03-31 | 2789.04x |
| 2006-12-31 | -3560.38x |
| 2006-09-30 | 1515.23x |
